{"transactions":[{"id":912487,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T01:55:33.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in equal monthly installments over a one-year period following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 1,719 shares of common stock and (ii) 35,000 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-18 reverse stock split effected by the Issuer on October 27, 2025, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":36719,"source":{"system":"sec-edgar","filing":"0001493152-26-006055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226006055/ownership.xml","form_type":"4"}},{"id":912470,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Acting CEO"}}],"security":"Common Stock","published_at":"2026-02-11T01:53:30.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in equal monthly installments over a one-year period following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 4,071 shares of common stock and (ii) 50,000 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-18 reverse stock split effected by the Issuer on October 27, 2025, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":54071,"source":{"system":"sec-edgar","filing":"0001493152-26-006053","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226006053/ownership.xml","form_type":"4"}},{"id":1099540,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":77664,"kind":"person","name":"LYTTON LAURENCE W","position":1,"cik":"0001105806","reported_name":"LYTTON LAURENCE W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T22:26:53.000Z","date":"2025-06-30","kind":"sale","planned":false,"acquired":false,"shares":400514,"price":1.39,"value":556714.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.47, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000935836-25-000440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1105806/000093583625000440/ownership.xml","form_type":"4"}},{"id":1099539,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":77664,"kind":"person","name":"LYTTON LAURENCE W","position":1,"cik":"0001105806","reported_name":"LYTTON LAURENCE W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T22:26:53.000Z","date":"2025-06-26","kind":"sale","planned":false,"acquired":false,"shares":466402,"price":1.5,"value":699603.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2."}],"balance_after":400514,"source":{"system":"sec-edgar","filing":"0000935836-25-000440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105806/000093583625000440/ownership.xml","form_type":"4"}},{"id":1165834,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-25T12:35:39.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":31326,"price":1.45,"value":45422.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":62668,"source":{"system":"sec-edgar","filing":"0001641172-25-006115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006115/ownership.xml","form_type":"4"}},{"id":1165833,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T12:35:38.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":27818,"price":1.45,"value":40336.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73292,"source":{"system":"sec-edgar","filing":"0001641172-25-006118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006118/ownership.xml","form_type":"4"}},{"id":1165832,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-25T12:35:37.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":11634,"price":1.45,"value":16869.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30958,"source":{"system":"sec-edgar","filing":"0001641172-25-006117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006117/ownership.xml","form_type":"4"}},{"id":1165830,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T12:35:35.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":23381,"price":1.45,"value":33902.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49126,"source":{"system":"sec-edgar","filing":"0001641172-25-006116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006116/ownership.xml","form_type":"4"}},{"id":1165831,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T12:35:34.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":4478,"price":1.45,"value":6493.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21301,"source":{"system":"sec-edgar","filing":"0001641172-25-006120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006120/ownership.xml","form_type":"4"}},{"id":1165829,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T12:35:33.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":23381,"price":1.45,"value":33902.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49139,"source":{"system":"sec-edgar","filing":"0001641172-25-006119","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006119/ownership.xml","form_type":"4"}},{"id":1184155,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:30:22.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":46728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the 45th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 32,363 shares of common stock and (ii) 68,747 unvested restricted stock units."}],"balance_after":101110,"source":{"system":"sec-edgar","filing":"0001641172-25-002391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225002391/ownership.xml","form_type":"4"}},{"id":1184154,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:30:18.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":46728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the 45th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 14,770 shares of common stock and (ii) 57,750 unvested restricted stock units."}],"balance_after":72520,"source":{"system":"sec-edgar","filing":"0001641172-25-002389","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225002389/ownership.xml","form_type":"4"}},{"id":1184153,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:30:03.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":46728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the 45th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 14,757 shares of common stock and (ii) 57,750 unvested restricted stock units."}],"balance_after":72507,"source":{"system":"sec-edgar","filing":"0001641172-25-002381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225002381/ownership.xml","form_type":"4"}},{"id":1276953,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-11T02:30:14.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":70671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in two equal installments on the 90th and 180th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 23,323 shares of common stock and (ii) 70,671 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":93994,"source":{"system":"sec-edgar","filing":"0001493152-25-005764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225005764/ownership.xml","form_type":"4"}},{"id":1276952,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-11T02:30:13.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":33922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in two equal installments on the 90th and 180th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 8,670 shares of common stock and (ii) 33,922 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":42592,"source":{"system":"sec-edgar","filing":"0001493152-25-005765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225005765/ownership.xml","form_type":"4"}},{"id":1276951,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-11T02:30:11.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":63604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in two equal installments on the 90th and 180th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 205,784 shares of common stock and (ii) 63,604 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":269388,"source":{"system":"sec-edgar","filing":"0001493152-25-005766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225005766/ownership.xml","form_type":"4"}},{"id":1365379,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T21:30:23.000Z","date":"2024-11-13","kind":"sale","planned":false,"acquired":false,"shares":2559,"price":3.28,"value":8393.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.36, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 32,363 shares of common stock and (ii) 22,019 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":54382,"source":{"system":"sec-edgar","filing":"0001493152-24-045937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224045937/ownership.xml","form_type":"4"}},{"id":1365378,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T21:30:23.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":14124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 34,922 shares of common stock and (ii) 22,019 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":56941,"source":{"system":"sec-edgar","filing":"0001493152-24-045937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224045937/ownership.xml","form_type":"4"}},{"id":1450043,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-23T12:05:35.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":1623,"price":3.67,"value":5956.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.67 to $3.72, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 14,770 shares of common stock and (ii) 11,022 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":25792,"source":{"system":"sec-edgar","filing":"0001493152-24-028778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224028778/ownership.xml","form_type":"4"}},{"id":1450042,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-23T12:05:33.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":1623,"price":3.68,"value":5972.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.67 to $3.76, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 14,757 shares of common stock and (ii) 11,022 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":25779,"source":{"system":"sec-edgar","filing":"0001493152-24-028777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224028777/ownership.xml","form_type":"4"}},{"id":1450039,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-23T12:05:32.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":1623,"price":3.67,"value":5956.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.67, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 14,757 shares of common stock and (ii) 11,022 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":25779,"source":{"system":"sec-edgar","filing":"0001493152-24-028776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224028776/ownership.xml","form_type":"4"}},{"id":1471006,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:33.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":36016,"price":0.69,"value":24851.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.71, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 282,534 shares of common stock and (ii) 145,622 unvested restricted stock units."}],"balance_after":428156,"source":{"system":"sec-edgar","filing":"0001493152-24-024964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024964/ownership.xml","form_type":"4"}},{"id":1471005,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:33.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 318,550 shares of common stock and (ii) 145,622 unvested restricted stock units."}],"balance_after":464172,"source":{"system":"sec-edgar","filing":"0001493152-24-024964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024964/ownership.xml","form_type":"4"}},{"id":1471004,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:31.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":35882,"price":0.69,"value":24758.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.74, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 132,649 shares of common stock and (ii) 141,496 unvested restricted stock units."}],"balance_after":274145,"source":{"system":"sec-edgar","filing":"0001493152-24-024962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024962/ownership.xml","form_type":"4"}},{"id":1471003,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:31.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 168,531 shares of common stock and (ii) 141,496 unvested restricted stock units."}],"balance_after":310027,"source":{"system":"sec-edgar","filing":"0001493152-24-024962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024962/ownership.xml","form_type":"4"}},{"id":1471002,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:30.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":36015,"price":0.69,"value":24850.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.71, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 132,516 shares of common stock and (ii) 141,496 unvested restricted stock units."}],"balance_after":274012,"source":{"system":"sec-edgar","filing":"0001493152-24-024963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024963/ownership.xml","form_type":"4"}},{"id":1471001,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:30.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 168,531 shares of common stock and (ii) 141,496 unvested restricted stock units."}],"balance_after":310027,"source":{"system":"sec-edgar","filing":"0001493152-24-024963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024963/ownership.xml","form_type":"4"}},{"id":1471000,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:29.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":36016,"price":0.69,"value":24851.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.73, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 132,515 shares of common stock and (ii) 141,496 unvested restricted stock units."}],"balance_after":274011,"source":{"system":"sec-edgar","filing":"0001493152-24-024961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024961/ownership.xml","form_type":"4"}},{"id":1470999,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:29.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 168,531 shares of common stock and (ii) 141,496 unvested restricted stock units."}],"balance_after":310027,"source":{"system":"sec-edgar","filing":"0001493152-24-024961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024961/ownership.xml","form_type":"4"}},{"id":1544719,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right-to-Buy)","published_at":"2024-04-10T00:58:44.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest over the next three (3) years in equal yearly installments on each anniversary of the grant date."}],"balance_after":170000,"derivative":{"exercise_price":0.6154,"exercise_date":"2025-04-08","expiration_date":"2034-04-08","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001493152-24-014120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224014120/ownership.xml","form_type":"4"}},{"id":1681781,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T23:30:07.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":66675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of November 12, 2024, a change in control of the Issuer, or the Reporting Person's death or disability. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 229,025 shares of common stock and (ii) 156,200 unvested restricted stock units."}],"balance_after":385225,"source":{"system":"sec-edgar","filing":"0001493152-24-001982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224001982/ownership.xml","form_type":"4"}},{"id":1698893,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-28T22:30:09.000Z","date":"2023-12-26","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in eleven (11) equal quarterly installments from February 29, 2024 to August 29, 2026. The options become exercisable upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The options will vest in eleven (11) equal quarterly installments from February 29, 2024 to August 29, 2026. The options become exercisable upon vesting."}],"balance_after":275000,"derivative":{"exercise_price":0.419,"expiration_date":"2032-08-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-23-046419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223046419/ownership.xml","form_type":"4"}},{"id":1698892,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-28T22:30:09.000Z","date":"2023-12-26","kind":"exercise","planned":false,"acquired":true,"shares":125000,"price":0.419,"value":52375.0,"ownership":{"direct":true},"balance_after":233227,"source":{"system":"sec-edgar","filing":"0001493152-23-046419","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223046419/ownership.xml","form_type":"4"}},{"id":1729694,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right-to-Buy)","published_at":"2023-11-27T23:35:08.000Z","date":"2023-11-24","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in their entirety on the first anniversary of the grant date."}],"balance_after":200000,"derivative":{"exercise_price":0.7,"exercise_date":"2024-11-24","expiration_date":"2033-11-24","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-23-042816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223042816/ownership.xml","form_type":"4"}},{"id":1771655,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T23:01:23.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":89525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 229,025 shares of common stock and (ii) 89,525 unvested restricted stock units."}],"balance_after":318550,"source":{"system":"sec-edgar","filing":"0001493152-23-034936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223034936/ownership.xml","form_type":"4"}},{"id":1771654,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T23:01:21.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":89525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 79,006 shares of common stock and (ii) 152,074 unvested restricted stock units."}],"balance_after":231080,"source":{"system":"sec-edgar","filing":"0001493152-23-034934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223034934/ownership.xml","form_type":"4"}},{"id":1771653,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T23:01:17.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":89525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 79,006 shares of common stock and (ii) 152,074 unvested restricted stock units."}],"balance_after":231080,"source":{"system":"sec-edgar","filing":"0001493152-23-034935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223034935/ownership.xml","form_type":"4"}},{"id":1771652,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T23:01:12.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":89525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 79,006 shares of common stock and (ii) 152,074 unvested restricted stock units."}],"balance_after":231080,"source":{"system":"sec-edgar","filing":"0001493152-23-034933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223034933/ownership.xml","form_type":"4"}},{"id":1779195,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-19T00:45:06.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":86700,"price":0.683,"value":59216.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.635 to $0.71, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":86700,"source":{"system":"sec-edgar","filing":"0001493152-23-032976","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223032976/ownership.xml","form_type":"4"}},{"id":1798875,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-24T01:39:23.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of (i) 254,505 vested stock options and (ii) 2,759,914 stock options that will vest in eleven equal quarterly installments from October 14, 2023 to April 14, 2026. The options become exercisable upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of (i) 254,505 vested stock options and (ii) 2,759,914 stock options that will vest in eleven equal quarterly installments from October 14, 2023 to April 14, 2026. The options become exercisable upon vesting."}],"balance_after":3014419,"derivative":{"exercise_price":0.419,"expiration_date":"2032-10-26","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-23-030021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223030021/ownership.xml","form_type":"4"}},{"id":1798874,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-24T01:39:23.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":true,"shares":1000000,"price":0.419,"value":419000.0,"ownership":{"direct":true},"balance_after":2057831,"source":{"system":"sec-edgar","filing":"0001493152-23-030021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223030021/ownership.xml","form_type":"4"}},{"id":1937076,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":21208,"kind":"person","name":"Howe Alan B","position":1,"cik":"0001296812","reported_name":"Howe Alan B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-28T22:00:11.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":1818,"price":0.6,"value":1090.8,"ownership":{"direct":true},"balance_after":176403,"source":{"system":"sec-edgar","filing":"0001493152-23-009332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223009332/ownership.xml","form_type":"4"}},{"id":2040540,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":67080,"kind":"person","name":"Crolius Clayton","position":1,"cik":"0001937013","reported_name":"Crolius Clayton","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right-to-Buy)","published_at":"2023-01-31T23:00:18.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in their entirety on the first anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":0.494,"exercise_date":"2024-01-27","expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-003189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223003189/ownership.xml","form_type":"4"}},{"id":2107249,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T22:01:25.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":141555,"source":{"system":"sec-edgar","filing":"0001493152-22-033376","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033376/ownership.xml","form_type":"4"}},{"id":2108887,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":21208,"kind":"person","name":"Howe Alan B","position":1,"cik":"0001296812","reported_name":"Howe Alan B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T02:45:24.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":174585,"source":{"system":"sec-edgar","filing":"0001493152-22-033220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033220/ownership.xml","form_type":"4"}},{"id":2108886,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":122236,"kind":"person","name":"Principe Jose Carlos","position":1,"cik":"0001941316","reported_name":"Principe Jose Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T02:45:22.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":149426,"source":{"system":"sec-edgar","filing":"0001493152-22-033221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033221/ownership.xml","form_type":"4"}},{"id":2108885,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right-to-Buy)","published_at":"2022-11-22T02:45:18.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":4014419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four-year period, with one quarter (1/4) of the options vesting on April 14, 2023 (the one-year anniversary of the date of the Reporting Person's appointment as CEO of Sonim Technologies, Inc.), and all remaining options vesting in equal quarterly installments in the amount of one-twelfth (1/12) of the remaining options amount thereafter."}],"balance_after":4014419,"derivative":{"exercise_price":0.419,"expiration_date":"2032-10-26","underlying":"Common Stock","underlying_shares":4014419},"source":{"system":"sec-edgar","filing":"0001493152-22-033223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033223/ownership.xml","form_type":"4"}},{"id":2108884,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T02:45:18.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":229025,"source":{"system":"sec-edgar","filing":"0001493152-22-033219","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033219/ownership.xml","form_type":"4"}},{"id":2108883,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T02:45:16.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":141555,"source":{"system":"sec-edgar","filing":"0001493152-22-033222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033222/ownership.xml","form_type":"4"}},{"id":2108882,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T02:45:14.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":141555,"source":{"system":"sec-edgar","filing":"0001493152-22-033218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033218/ownership.xml","form_type":"4"}},{"id":2137183,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":122236,"kind":"person","name":"Principe Jose Carlos","position":1,"cik":"0001941316","reported_name":"Principe Jose Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T20:06:44.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":101694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 15,980 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 15,980 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."}],"balance_after":101694,"source":{"system":"sec-edgar","filing":"0001493152-22-028458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222028458/ownership.xml","form_type":"4/A","original_submission_date":"2022-08-09"}},{"id":2137182,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T20:06:42.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":93823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 8,109 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 8,109 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."}],"balance_after":93823,"source":{"system":"sec-edgar","filing":"0001493152-22-028456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222028456/ownership.xml","form_type":"4/A","original_submission_date":"2022-08-09"}},{"id":2137181,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T20:06:40.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":93823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 8,109 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 8,109 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."}],"balance_after":93823,"source":{"system":"sec-edgar","filing":"0001493152-22-028457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222028457/ownership.xml","form_type":"4/A","original_submission_date":"2022-08-09"}},{"id":2137180,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T20:06:30.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":93823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 8,109 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person's previously filed Form 4 inadvertently (i) understated the number of shares of common stock of Sonim Technologies, Inc. (the \"Issuer\") disclosed in Columns 4 and 5 by 8,109 shares due to a mathematical error in the calculation of the value of shares for the purpose of issuance and (ii) incorrectly described the vesting schedule of issued restricted stock units (the \"RSUs\"). The RSUs vest in three equal annual installments on the anniversary date on which the Reporting Person was appointed as a director of the Issuer's board, subject to continuous service on each vesting date. This Form 4 corrects the above-described errors by increasing the number of shares and the total amount of securities beneficially owned by the Reporting Person."}],"balance_after":93823,"source":{"system":"sec-edgar","filing":"0001493152-22-028455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222028455/ownership.xml","form_type":"4/A","original_submission_date":"2022-08-09"}},{"id":2189815,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":124728,"kind":"organization","name":"AJP Holding Company, LLC","position":1,"cik":"0001932469","reported_name":"AJP Holding Company, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:15:46.000Z","date":"2022-08-08","kind":"purchase","acquired":true,"shares":5534881,"price":0.84,"value":4649300.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased and held by the Reporting Person immediately after the second closing pursuant to the subscription agreement dated April 13, 2022 by and between the Reporting Person and Sonim Technologies, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares purchased and held by the Reporting Person immediately after the second closing pursuant to the subscription agreement dated April 13, 2022 by and between the Reporting Person and Sonim Technologies, Inc."}],"balance_after":19463452,"source":{"system":"sec-edgar","filing":"0001493152-22-021893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021893/ownership.xml","form_type":"4"}},{"id":2191165,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T00:36:35.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":181293,"source":{"system":"sec-edgar","filing":"0001493152-22-021818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021818/ownership.xml","form_type":"4"}},{"id":2191164,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80506,"kind":"person","name":"Steenstra Jack","position":1,"cik":"0001936052","reported_name":"Steenstra Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T23:13:37.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":85714,"source":{"system":"sec-edgar","filing":"0001493152-22-021816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021816/ownership.xml","form_type":"4"}},{"id":2191175,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":21208,"kind":"person","name":"Howe Alan B","position":1,"cik":"0001296812","reported_name":"Howe Alan B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T23:12:11.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":126853,"source":{"system":"sec-edgar","filing":"0001493152-22-021815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021815/ownership.xml","form_type":"4"}},{"id":2191162,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":122236,"kind":"person","name":"Principe Jose Carlos","position":1,"cik":"0001941316","reported_name":"Principe Jose Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T23:10:47.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":85714,"source":{"system":"sec-edgar","filing":"0001493152-22-021814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021814/ownership.xml","form_type":"4"}},{"id":2191161,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80507,"kind":"person","name":"Cassano James S","position":1,"cik":"0001343514","reported_name":"Cassano James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T23:09:31.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":85714,"source":{"system":"sec-edgar","filing":"0001493152-22-021813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021813/ownership.xml","form_type":"4"}},{"id":2191160,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T23:07:58.000Z","date":"2022-08-08","kind":"purchase","acquired":true,"shares":5534881,"price":0.84,"value":4649300.04,"ownership":{"direct":false,"nature":"By AJP Holding Company, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares purchased and held by AJP Holding Company, LLC immediately after the second closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares purchased and held by AJP Holding Company, LLC immediately after the second closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Person is the sole manager of AJP Holding Company, LLC and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":19463452,"source":{"system":"sec-edgar","filing":"0001493152-22-021812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021812/ownership.xml","form_type":"4"}},{"id":2191159,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T23:07:58.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":85714,"source":{"system":"sec-edgar","filing":"0001493152-22-021812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021812/ownership.xml","form_type":"4"}},{"id":2207153,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former President, CFO & COO"}}],"security":"Common Stock","published_at":"2022-07-15T23:40:09.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":729,"price":0.7587,"value":553.0923,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit (\"RSU\") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs."}],"balance_after":314619,"source":{"system":"sec-edgar","filing":"0000899243-22-026172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924322026172/doc4.xml","form_type":"4"}},{"id":2207152,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former President, CFO & COO"}}],"security":"Common Stock","published_at":"2022-07-15T23:40:09.000Z","date":"2022-07-13","kind":"sale","acquired":false,"shares":9176,"price":0.5436,"value":4988.0736,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit (\"RSU\") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs."}],"balance_after":315348,"source":{"system":"sec-edgar","filing":"0000899243-22-026172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924322026172/doc4.xml","form_type":"4"}},{"id":2207593,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80508,"kind":"person","name":"Wang Jeffrey","position":1,"cik":"0001935353","reported_name":"Wang Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T01:01:10.000Z","date":"2022-07-13","kind":"purchase","acquired":true,"shares":13928571,"price":0.84,"value":11699999.64,"ownership":{"direct":false,"nature":"By AJP Holding Company, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased and held by AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares purchased and held by AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares purchased and held by AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole manager of AJP Holding Company, LLC and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":13928571,"source":{"system":"sec-edgar","filing":"0001493152-22-019366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222019366/ownership.xml","form_type":"4"}},{"id":2207594,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-15T00:59:09.000Z","date":"2022-07-13","kind":"purchase","acquired":true,"shares":952381,"price":0.84,"value":800000.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued to the reporting person as a designee of AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares issued to the reporting person as a designee of AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares issued to the reporting person as a designee of AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."}],"balance_after":1059867,"source":{"system":"sec-edgar","filing":"0001493152-22-019364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222019364/ownership.xml","form_type":"4"}},{"id":2224413,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO and COO"}}],"security":"Common Stock","published_at":"2022-06-22T20:13:41.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":10361,"price":0.54,"value":5594.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit (\"RSU\") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.54 to $0.5414, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 32,124 RSUs.  Each RSU represents the right to receive one share of the Issuer's common stock."}],"balance_after":324524,"source":{"system":"sec-edgar","filing":"0000899243-22-023558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924322023558/doc4.xml","form_type":"4"}},{"id":2234466,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO and COO"}}],"security":"Common Stock","published_at":"2022-06-13T21:38:20.000Z","date":"2022-06-10","kind":"sale","acquired":false,"shares":4493,"price":0.575,"value":2583.475,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit (\"RSU\") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.57 to $0.585, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 65,619 RSUs.  Each RSU represents the right to receive one share of the Issuer's common stock."}],"balance_after":334885,"source":{"system":"sec-edgar","filing":"0000899243-22-022227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924322022227/doc4.xml","form_type":"4"}},{"id":2421274,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO and COO"}}],"security":"Common Stock","published_at":"2022-01-31T21:07:39.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":233638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,250 shares of the Issuer's common stock that were purchased by the Reporting Person under the Issuer's employee stock purchase plan since the last filing of a Form 4 by the Reporting Person."}],"balance_after":339378,"source":{"system":"sec-edgar","filing":"0000899243-22-003634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924322003634/doc4.xml","form_type":"4"}},{"id":2511179,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T21:41:55.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":13953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of  stockholders, a change in control of the Issuer or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":95579,"source":{"system":"sec-edgar","filing":"0000899243-21-044827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321044827/doc4.xml","form_type":"4"}},{"id":2511178,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":21208,"kind":"person","name":"Howe Alan B","position":1,"cik":"0001296812","reported_name":"Howe Alan B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T21:39:59.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":27906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of  stockholders, a change in control of the Issuer or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021."}],"balance_after":41139,"source":{"system":"sec-edgar","filing":"0000899243-21-044823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321044823/doc4.xml","form_type":"4"}},{"id":2511177,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":133486,"kind":"person","name":"Kneuer John","position":1,"cik":"0001512329","reported_name":"Kneuer John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T21:33:44.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":27906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of  stockholders, a change in control of the Issuer or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021."}],"balance_after":40220,"source":{"system":"sec-edgar","filing":"0000899243-21-044818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321044818/doc4.xml","form_type":"4"}},{"id":2511579,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":12283,"kind":"person","name":"SWENSON SUSAN","position":1,"cik":"0001112671","reported_name":"SWENSON SUSAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T16:40:39.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":27906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of  stockholders, a change in control of the Issuer or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021."}],"balance_after":39806,"source":{"system":"sec-edgar","filing":"0000899243-21-044825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1112671/000089924321044825/doc4.xml","form_type":"4"}},{"id":2541837,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T21:11:54.000Z","date":"2021-10-08","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021."}],"balance_after":81626,"source":{"system":"sec-edgar","filing":"0000899243-21-040377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321040377/doc4.xml","form_type":"4"}},{"id":79194,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":2815,"kind":"organization","name":"MORGAN STANLEY","symbol":"MS","position":1,"cik":"0000895421","reported_name":"MORGAN STANLEY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-14T16:49:09.000Z","date":"2021-10-12","kind":"sale","acquired":false,"shares":60000,"ownership":{"direct":false,"nature":"By Subsidiary"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The price reported in Column 4 is a weighted average price of $2.02. The shares were sold in multiple transactions at prices ranging from $1.99 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price of $2.02. The shares were sold in multiple transactions at prices ranging from $1.99 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":846629,"source":{"system":"sec-edgar","filing":"0000899243-21-040203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895421/000089924321040203/doc4.xml","form_type":"4"}},{"id":2571096,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO and COO"}}],"security":"Common Stock","published_at":"2021-09-15T01:00:13.000Z","date":"2021-09-10","kind":"sale","acquired":false,"shares":6417,"price":0.67,"value":4299.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit (\"RSU\") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 795,702 restricted stock units."}],"balance_after":1044889,"source":{"system":"sec-edgar","filing":"0000899243-21-035919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321035919/doc4.xml","form_type":"4"}},{"id":2591122,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T21:31:09.000Z","date":"2021-08-25","kind":"sale","acquired":false,"shares":1500000,"price":0.4118,"value":617700.0,"ownership":{"direct":false,"nature":"By BRC Partners Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":2903765,"source":{"system":"sec-edgar","filing":"0001213900-21-044829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021044829/ownership.xml","form_type":"4"}},{"id":2591121,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T21:31:09.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":1160078,"price":0.4087,"value":474123.8786,"ownership":{"direct":false,"nature":"By BRC Partners Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":4403765,"source":{"system":"sec-edgar","filing":"0001213900-21-044829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021044829/ownership.xml","form_type":"4"}},{"id":2591120,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T21:31:09.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":176482,"price":0.3966,"value":69992.7612,"ownership":{"direct":false,"nature":"By BRC Partners Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":5563843,"source":{"system":"sec-edgar","filing":"0001213900-21-044829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021044829/ownership.xml","form_type":"4"}},{"id":2661557,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO and COO"}}],"security":"Common Stock","published_at":"2021-06-21T20:23:00.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":334952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on June 18, 2022."}],"balance_after":1051306,"source":{"system":"sec-edgar","filing":"0001438223-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000143822321000003/primary_doc.xml","form_type":"4"}},{"id":2661556,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":138072,"kind":"person","name":"NAUMANN KENNETH DALE","position":1,"cik":"0001505638","reported_name":"NAUMANN KENNETH DALE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:01:58.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":66265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the first to occur of the issuer's 2022 annual meeting of stockholders or June 17, 2022."}],"balance_after":66265,"source":{"system":"sec-edgar","filing":"0001505638-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000150563821000004/primary_doc.xml","form_type":"4"}},{"id":2661555,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T19:53:59.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":66265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the first to occur of the issuer's 2022 annual meeting of stockholders or June 17, 2022."}],"balance_after":66265,"source":{"system":"sec-edgar","filing":"0001211437-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121143721000002/primary_doc.xml","form_type":"4"}},{"id":2672347,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":125368,"kind":"person","name":"TIRVA ROBERT L.","position":1,"cik":"0001438223","reported_name":"TIRVA ROBERT L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CFO and COO"}}],"security":"Common Stock","published_at":"2021-06-12T01:30:12.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":42891,"price":0.64,"value":27450.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit (\"RSU\") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 481,875 RSUs and (ii) 10,380 and 11,691 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on November 13, 2020 and May 14, 2021, respectively."}],"balance_after":716354,"source":{"system":"sec-edgar","filing":"0000899243-21-023443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321023443/doc4.xml","form_type":"4"}},{"id":2779620,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":817,"price":0.9377,"value":766.1009,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Abigail Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":24302,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779619,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":817,"price":0.9377,"value":766.1009,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Eloise Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":24303,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779618,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":817,"price":0.9377,"value":766.1009,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Charlie Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":24303,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779617,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":817,"price":0.9377,"value":766.1009,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Susan Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":24303,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779616,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":4832,"price":0.9971,"value":4817.9872,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Abigail Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":25119,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779615,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":4832,"price":0.9971,"value":4817.9872,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Eloise Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":25120,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779614,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":4832,"price":0.9971,"value":4817.9872,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Charlie Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":25120,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2779613,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T22:36:26.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":4832,"price":0.9971,"value":4817.9872,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Susan Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":25120,"source":{"system":"sec-edgar","filing":"0001213900-21-016437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021016437/ownership.xml","form_type":"4"}},{"id":2789503,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-13","kind":"sale","acquired":false,"shares":16715,"price":1.0083,"value":16853.7345,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Abigail Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":29951,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789502,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-13","kind":"sale","acquired":false,"shares":16715,"price":1.0083,"value":16853.7345,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Eloise Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":29952,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789501,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-13","kind":"sale","acquired":false,"shares":16715,"price":1.0083,"value":16853.7345,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Charlie Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":29952,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789500,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-13","kind":"sale","acquired":false,"shares":16715,"price":1.0083,"value":16853.7345,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Susan Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":29952,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789499,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-13","kind":"sale","acquired":false,"shares":3000,"price":1.001,"value":3003.0,"ownership":{"direct":false,"nature":"By BRC Partners Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":5740325,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789498,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":100000,"price":0.9914,"value":99140.0,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Abigail Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":46666,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789497,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":100000,"price":0.9914,"value":99140.0,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Eloise Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":46667,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789496,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":100000,"price":0.9914,"value":99140.0,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Charlie Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":46667,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}},{"id":2789495,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":6050,"kind":"organization","name":"BRC Group Holdings, Inc.","position":1,"cik":"0001464790","reported_name":"B. Riley Financial, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134384,"kind":"organization","name":"BRC Partners Opportunity Fund, LP","position":2,"cik":"0001642765","reported_name":"BRC Partners Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134383,"kind":"organization","name":"BRC Partners Management GP, LLC","position":3,"cik":"0001749420","reported_name":"BRC Partners Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105927,"kind":"organization","name":"B. RILEY CAPITAL MANAGEMENT, LLC","position":4,"cik":"0001658704","reported_name":"B. RILEY CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92652,"kind":"organization","name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","position":5,"cik":"0001776226","reported_name":"B. RILEY PRINCIPAL INVESTMENTS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37663,"kind":"person","name":"RILEY BRYANT R","position":6,"cik":"0001207269","reported_name":"RILEY BRYANT R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T22:58:34.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":100000,"price":0.9914,"value":99140.0,"ownership":{"direct":false,"nature":"By Bryant R. Riley, as UTMA custodian for Susan Riley"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed jointly by B. Riley Financial, Inc., a Delaware corporation (\"BRF\"), BRC Partners Opportunity Fund, LP, a Delaware limited partnership (\"BRPLP\"), BRC Partners Management GP, LLC, a Delaware limited liability company (\"BRPGP\"), B. Riley Capital Management, LLC, a New York limited liability company, a registered investment advisor (\"BRCM\"), B. Riley Principal Investments, LLC, a Delaware limited liability company (\"BRPI\"), and Bryant R. Riley. BRPGP is a subsidiary of BRCM and is the general partner of BRPLP. BRF is the parent company of BRCM. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPLP. BRF is the parent company of BRPI. As a result, BRF may be deemed to indirectly beneficially own the shares held by BRPI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bryant R. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the shares of Common Stock directly held by BRF, BRPLP, and BRPI. Each of BRF, BRPLP, BRPGP, BRCM, and BRPI (collectively, the \"B. Riley Entities\") and Bryant R. Riley disclaims beneficial ownership of the outstanding shares of Common Stock reported herein, except to the extent of its/his respective pecuniary interest therein."}],"balance_after":46667,"source":{"system":"sec-edgar","filing":"0001213900-21-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121390021015456/ownership.xml","form_type":"4"}}],"next_cursor":"2021-03-15T22:58:34.000000Z,2789495"}